Phibro Animal Health Corporation $PAHC Shares Sold by State of Wyoming

Key Points

• The State of Wyoming significantly reduced its holdings in Phibro Animal Health Corporation by 81.2% in Q1, owning only 2,656 shares worth approximately $57,000 after selling 11,504 shares.
• Multiple institutional investors, including Trexquant Investment LP and Brant Point Investment Management LLC, established new positions in Phibro Animal Health, reflecting a growing interest in the stock.
• Phibro recently announced a quarterly dividend of $0.12 per share, with an annualized yield of 1.2%, set to be paid on September 24th.

State of Wyoming decreased its stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 81.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,656 shares of the company's stock after selling 11,504 shares during the quarter. State of Wyoming's holdings in Phibro Animal Health were worth $57,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Man Group plc purchased a new stake in shares of Phibro Animal Health during the fourth quarter worth about $501,000. GAMMA Investing LLC grew its position in shares of Phibro Animal Health by 2,011.4% during the first quarter. GAMMA Investing LLC now owns 36,718 shares of the company's stock worth $784,000 after purchasing an additional 34,979 shares in the last quarter. LPL Financial LLC grew its position in shares of Phibro Animal Health by 46.8% during the first quarter. LPL Financial LLC now owns 128,335 shares of the company's stock worth $2,741,000 after purchasing an additional 40,889 shares in the last quarter. Lazard Asset Management LLC grew its position in shares of Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares in the last quarter. Finally, Nuveen Asset Management LLC grew its position in shares of Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after purchasing an additional 103,618 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently commented on PAHC shares. Bank of America increased their price target on Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a research note on Friday, August 29th. JPMorgan Chase & Co. raised Phibro Animal Health from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $25.00 to $35.00 in a research note on Monday, July 7th. BNP Paribas raised Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Morgan Stanley set a $34.00 price objective on Phibro Animal Health in a research note on Thursday, August 28th. Finally, BNP Paribas Exane raised Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a research note on Monday, June 16th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company has an average rating of "Reduce" and a consensus target price of $28.40.

Phibro Animal Health Stock Up 1.2%

PAHC stock traded up $0.48 on Monday, hitting $40.10. 21,801 shares of the company's stock were exchanged, compared to its average volume of 274,523. Phibro Animal Health Corporation has a 12-month low of $16.16 and a 12-month high of $41.57. The firm has a 50 day moving average price of $31.98 and a two-hundred day moving average price of $25.55. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.25 and a current ratio of 2.76. The stock has a market cap of $1.63 billion, a P/E ratio of 33.98, a price-to-earnings-growth ratio of 1.18 and a beta of 0.88.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.05. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%.The firm had revenue of $378.70 million for the quarter, compared to the consensus estimate of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, equities research analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.2%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health's payout ratio is presently 40.68%.

Insiders Place Their Bets

In other Phibro Animal Health news, CEO Jack Bendheim sold 3,520 shares of the business's stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $41.29, for a total transaction of $145,340.80. Following the sale, the chief executive officer owned 41,880 shares in the company, valued at approximately $1,729,225.20. The trade was a 7.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 50.07% of the company's stock.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.